Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Goodwill & Intangibles (2009 - 2026)

Bio-Techne (TECH) posted quarterly Goodwill & Intangibles of $1.9 billion for Q1 2026, up 32.67% year-over-year from $1.4 billion in Q1 2025, and up 42.43% quarter-over-quarter from $1.3 billion in Q4 2025.

Analysis

Bio-Techne (TECH) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Bio-Techne's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $1.9 billion for Q1 2026.

  • In Q1 2026, Goodwill & Intangibles rose 32.67% year-over-year to $1.9 billion; the TTM figure through Mar 2026 stood at $1.9 billion (up 32.67% YoY), while the FY2025 annual figure was $1.3 billion, up 29.59% from the prior year.
  • Goodwill & Intangibles for Q1 2026 stood at $1.9 billion, up from $1.3 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $1.9 billion in Q1 2026, with the low at $27.1 million in Q1 2022.
  • The 5-year median for Goodwill & Intangibles is $1.3 billion (2025), against an average of $1.2 billion.
  • Peak annual rise in Goodwill & Intangibles reached 3195.24% in 2023, while the deepest fall reached 53.03% in 2023.
  • Bio-Techne's Goodwill & Intangibles stood at $945.2 million in 2022, then soared by 59.54% to $1.5 billion in 2023, then fell by 5.46% to $1.4 billion in 2024, then dropped by 7.72% to $1.3 billion in 2025, then jumped by 42.43% to $1.9 billion in 2026.
  • Business Quant data shows TECH's Goodwill & Intangibles at $1.9 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.87 Bn
Mar 31, 2026 1.87 Bn
Dec 31, 2025 1.88 Bn
Sep 30, 2025 1.88 Bn
Jun 30, 2025 1.98 Bn
Mar 31, 2025 2.02 Bn
Dec 31, 2024 1.43 Bn
Sep 30, 2024 1.47 Bn
Jun 30, 2024 1.48 Bn
Mar 31, 2024 628.97 Mn
Dec 31, 2023 653.15 Mn
Sep 30, 2023 681.53 Mn
Jun 30, 2023 1.41 Bn
Mar 31, 2023 604.31 Mn
Dec 31, 2022 618.70 Mn
Sep 30, 2022 636.59 Mn
Jun 30, 2022 1.35 Bn
Mar 31, 2022 555.75 Mn
Dec 31, 2021 1.40 Bn
Sep 30, 2021 1.46 Bn